HayTox is the clinic’s term for intranasal botulinum toxin type A (BTX/A) treatment for allergic rhinitis (hay fever).

This needle-free treatment involves delivering a fine mist of BTX/A into the nasal passages using a specialised atomiser — no injections are required.

By modulating overactive nasal gland activity, the treatment may help reduce symptoms such as:

• Excessive nasal discharge
• Persistent congestion
• Sneezing related to allergic triggers

🕒 Onset
Improvement typically develops within 1–2 weeks.

⏳ Longevity
Effects may last up to 3 months. Treatment can be repeated if clinically appropriate.

Suitability is assessed on an individual basis following medical consultation.